Healthcare & Life Sciences
Seragon Pharmaceuticals
United States
acquired
acquired
Stage
1
Investors
About
Seragon Pharmaceuticals develops small molecule therapies targeting hormone-related cancers, focusing on treating breast cancer through inhibition of key pathways involved in tumor growth.
Explore Seragon Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.